CORC

在结果中检索

CORC

浏览/检索结果: 共24条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Copper-mediated C-H thiolation of (hetero)arenes using weakly coordinating directing group 期刊论文
TETRAHEDRON LETTERS, 2020, 卷号: 61, 期号: 28, 页码: 4
作者:  Wu, Peng;  Cheng, Tai-Jin;  Lin, Hai-Xia;  Xu, Hui;  Dai, Hui-Xiong
收藏  |  浏览/下载：12/0  |  提交时间：2020/12/24
Metastases to the nose from clear cell renal cell carcinoma A case report 期刊论文
MEDICINE, 2019, 卷号: 98, 期号: 4
作者:  Wang, Xinhui;  Yang, Lei;  Qu, Limei;  Liu, Ziling;  Cui, Pengfei
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III data 期刊论文
2019, 卷号: 15, 期号: 1, 页码: 3267-3278
作者:  Sheng, Xinan;  Bi, Feng;  Ren, Xiubao;  Cheng, Ying;  Wang, Jinwan
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 160, 页码: 61-81
作者:  Liu, Xuesong;  Wang, Beilei;  Chen, Cheng;  Jiang, Zongru;  Hu, Chen
收藏  |  浏览/下载：14/0  |  提交时间：2019/01/11
Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial 期刊论文
ANNALS OF ONCOLOGY, 2018, 卷号: 29, 期号: 12
作者:  Gross-Goupil, M.;  Kwon, T. G.;  Eto, M.;  Ye, D.;  Miyake, H.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China 期刊论文
JOURNAL OF MEDICAL ECONOMICS, 2018, 卷号: 21, 期号: 12
作者:  Shi, Guohai;  Park, Sang Hee;  Ren, Hongye;  Xue, Mei;  Lu, Xiaolin
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Axitinib vs placebo in patients at high risk of recurrent renal cell carcinoma (RCC): ATLAS trial results 会议论文
作者:  Gross-Goupil, M.;  Kwon, T. G.;  Eto, M.;  Ye, D.;  Miyake, H.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Visualization and Quantification of Browning Using a Ucp1-2A-Luciferase Knock-in Mouse Model. 期刊论文
DIABETES, 2017
作者:  Mao, Liufeng;  Nie, Baoming;  Nie, Tao;  Hui, Xiaoyan;  Gao, Xuefei
收藏  |  浏览/下载：51/0  |  提交时间：2018/02/02
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of data from a phase III trial 期刊论文
ANNALS OF ONCOLOGY, 2017, 卷号: Vol.28, 页码: 82
作者:  Sheng, X;  Bi, F;  Ren, X;  Cheng, Y;  Wang, J
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/28
First-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma (mRCC): Subgroup analysis of data from a phase III trial 期刊论文
2017, 卷号: 28, 页码: 82-82
作者:  Sheng, X.;  Bi, F.;  Ren, X.;  Cheng, Y.;  Wang, J.
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace